Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04487912 | Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer | withdrawn | Phase 4 | 0 | University Hospital, GhentOTHER | 1 | May 14, 2021 | clinicaltrials |
| NCT02822196 | Serratus Anterior Muscle Plane Block vsThoracic Paravertebral Block For Unilateral Mastectomies | withdrawn | Phase 4 | 0 | The University of Texas Health Science Center, HoustonOTHER | 1 | Sep 16, 2020 | clinicaltrials |
| NCT03988114 | A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer(proMONARCH) | withdrawn | Phase 4 | 0 | Eli Lilly and CompanyINDUSTRY | 9 | Sep 6, 2019 | clinicaltrials |
| NCT03238703 | Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer | withdrawn | Phase 4 | 0 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 27, 2018 | clinicaltrials |
| NCT02372305 | Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery | withdrawn | Phase 4 | 0 | University of ArkansasOTHER | 1 | Jul 18, 2018 | clinicaltrials |
| NCT00774241 | PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer | withdrawn | Phase 4 | 0 | Hoffmann-La RocheINDUSTRY | 0 | Nov 2, 2016 | clinicaltrials |
| NCT01156961 | A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX) | withdrawn | Phase 4 | 0 | Hoffmann-La RocheINDUSTRY | 0 | Nov 2, 2016 | clinicaltrials |
| NCT01943240 | Pectoral Nerve Blockade in Mastectomy | withdrawn | Phase 4 | 0 | Timothy R PetersenOTHER | 1 | Oct 27, 2016 | clinicaltrials |
Data updated 23 days agoSource updated May 14, 2021source: clinicaltrials